Unlike finasteride, which is not approved for women, copper peptides work through non-hormonal pathways: Follicle enlargement via Wnt/beta-catenin signalling Improved scalp circulation via angiogenesis Anti-inflammatory protection reducing follicle miniaturisation Women experiencing diffuse thinning, post-partum shedding, or early-stage androgenetic alopecia can all benefit from regular use
adverse effects associated with ipamorelin treatment are rare and similar to those reported with sermorelin [6]
Zodasiran, a siRNA inhibiting ANGPTL3 mRNA, has not yet received the EMA and FDA approval (phase 3 randomized controlled trial ongoing)
Generally described as well tolerated in available studies and clinical use reports when introduced gradually
Vegan, gluten-free, and bioavailable ingredients with no unnecessary fillers
Molecular mechanisms of dietary restriction promoting health and longevity